Chemopreventive effect of ursodeoxycholic acid in primary sclerosing cholangitis?

2007 ◽  
pp. 242-249
Author(s):  
B. Brandsæter ◽  
H. Isoniemi ◽  
U. Broomé ◽  
M. Olausson ◽  
L. Bäckman ◽  
...  
Keyword(s):  
Ursodeoxycholic Acid ◽  
Primary Sclerosing Cholangitis ◽  
Sclerosing Cholangitis ◽  
Chemopreventive Effect

A case of symptomatic primary sclerosing cholangitis treated with ursodeoxycholic acid.

Kanzo ◽  
1992 ◽  
Vol 33 (7) ◽  
pp. 552-555
Author(s):  
Motoyoshi YANO ◽  
Hirotomo TAKESHIMA ◽  
Naoki HISHIDA ◽  
Hisao HAYASHI ◽  
Nobuo SAKAMOTO
Keyword(s):  
Ursodeoxycholic Acid ◽  
Primary Sclerosing Cholangitis ◽  
Sclerosing Cholangitis

scholarly journals Oral vancomycin, ursodeoxycholic acid or no therapy for pediatric primary sclerosing cholangitis: a matched analysis

Hepatology ◽  
2020 ◽  
Author(s):  
Mark R. Deneau ◽  
Cara Mack ◽  
Douglas Mogul ◽  
Emily R. Perito ◽  
Pamela L. Valentino ◽  
...  
Keyword(s):  
Ursodeoxycholic Acid ◽  
Primary Sclerosing Cholangitis ◽  
Sclerosing Cholangitis ◽  
Oral Vancomycin

scholarly journals Primary sclerosing cholangitis and pregnancy

2011 ◽  
Vol 1 (3) ◽  
pp. 55 ◽  
Author(s):  
Casper Q. Kammeijer ◽  
Robert A. De Man ◽  
Christianne J.M. De Groot
Keyword(s):  
Ursodeoxycholic Acid ◽  
Primary Sclerosing Cholangitis ◽  
Sclerosing Cholangitis ◽  
Rare Case ◽  
Progressive Disease ◽  
High Dose ◽  
Term Outcome ◽  
Long Term Outcome ◽  
In Pregnancy

Primary sclerosing cholangitis is a progressive disease, and coincidentally in pregnancy it is rare. It is characterized by progressive inflammation and destruction of bile ducts finally resulting in liver failure. A rare case of primary sclerosing cholangitis in pregnancy is presented. The course of the pregnancy was marked by threatened preterm delivery and exacerbation of cholestasis. She was successfully treated with ursodeoxycholic acid (UDCA). Although, primary sclerosing cholangitis has both maternal and fetal effects on pregnancy, the overall outcome is favorable. Only few cases have been reported using high dose ursodeoxycholic acid for primary sclerosing cholangitis in pregnancy, it often improves pruritus but has no protection against stillbirth. Data on the safety to the fetus or neonate and long-term outcome are scarce.

632 Four-year outcome of primary sclerosing cholangitis (PSC) under low-dose ursodeoxycholic acid (UDCA): A French prospective study

2006 ◽  
Vol 44 ◽  
pp. S234-S235 ◽  
Author(s):  
A. Garioud ◽  
P. Seksik ◽  
Y. Chretien ◽  
C. Corpechot ◽  
R. Poupon ◽  
...  
Keyword(s):  
Prospective Study ◽  
Ursodeoxycholic Acid ◽  
Primary Sclerosing Cholangitis ◽  
Sclerosing Cholangitis ◽  
Low Dose
Sign in / Sign up

Export Citation Format

Share Document